NT_1170x120_1-11-18

Alzheimer’s disease

CVS Health Foundation expands support of Alzheimer’s program

CVS Health Foundation expands support of Alzheimer’s program

WOONSOCKET, R.I. — The CVS Health Foundation is making a $550,000 grant to the Alzheimer’s Association to boost its support for a new program to enhance disease diagnosis and assessment with clinicians and to educate them about care and support programs to help families. CVS said the grant, which is being shared with six local

Upsher-Smith gains approval for Namenda generic

MAPLE GROVE, Minn. — Upsher-Smith Laboratories Inc. has received approval from the Food and Drug Administration of an Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, a treatment for Alzheimer’s disease, in strengths of 5 mg and 10 mg. Upsher-Smith said Monday that its product is a generic version of Namenda from Forest Laboratories,